PL2435406T3 - Rozdzielanie (±)-fenylo[4-[4-[[[4'-(trifluorometylo)-2-bifenylilo]karbonylo]amino]fenylo]-1-piperydynylo] octanu metylu - Google Patents

Rozdzielanie (±)-fenylo[4-[4-[[[4'-(trifluorometylo)-2-bifenylilo]karbonylo]amino]fenylo]-1-piperydynylo] octanu metylu

Info

Publication number
PL2435406T3
PL2435406T3 PL10724047T PL10724047T PL2435406T3 PL 2435406 T3 PL2435406 T3 PL 2435406T3 PL 10724047 T PL10724047 T PL 10724047T PL 10724047 T PL10724047 T PL 10724047T PL 2435406 T3 PL2435406 T3 PL 2435406T3
Authority
PL
Poland
Prior art keywords
phenyl
biphenylyl
piperidinyl
trifluoromethyl
carbonyl
Prior art date
Application number
PL10724047T
Other languages
English (en)
Inventor
Alex Herman Copmans
Jérôme Albert Joseph HOET
Albert Louis Anna Willemsens
Wouter Louis J Couck
Dun Joannes Petrus Van
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PL2435406T3 publication Critical patent/PL2435406T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL10724047T 2009-05-29 2010-05-27 Rozdzielanie (±)-fenylo[4-[4-[[[4'-(trifluorometylo)-2-bifenylilo]karbonylo]amino]fenylo]-1-piperydynylo] octanu metylu PL2435406T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09161460 2009-05-29
PCT/EP2010/057319 WO2010136526A1 (en) 2009-05-29 2010-05-27 Resolution of (±)-methyl phenyl[4-[4-[[[4'-(trifluoromethyl)-2-biphenylyl]carbonyl]amino]phenyl]-1-piperidinyl]acetate
EP10724047A EP2435406B1 (en) 2009-05-29 2010-05-27 Resolution of (±)-methyl phenyl[4-[4-[[[4'-(trifluoromethyl)-2-biphenylyl]carbonyl]amino]phenyl]-1-piperidinyl]acetate

Publications (1)

Publication Number Publication Date
PL2435406T3 true PL2435406T3 (pl) 2013-07-31

Family

ID=40973200

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10724047T PL2435406T3 (pl) 2009-05-29 2010-05-27 Rozdzielanie (±)-fenylo[4-[4-[[[4'-(trifluorometylo)-2-bifenylilo]karbonylo]amino]fenylo]-1-piperydynylo] octanu metylu

Country Status (16)

Country Link
US (1) US8461341B2 (pl)
EP (1) EP2435406B1 (pl)
JP (1) JP5596134B2 (pl)
KR (1) KR101658880B1 (pl)
CN (1) CN102448934B (pl)
AU (1) AU2010251910B2 (pl)
CA (1) CA2757702C (pl)
CY (1) CY1114406T1 (pl)
DK (1) DK2435406T3 (pl)
EA (1) EA018296B1 (pl)
ES (1) ES2412081T3 (pl)
HR (1) HRP20130393T1 (pl)
PL (1) PL2435406T3 (pl)
PT (1) PT2435406E (pl)
SI (1) SI2435406T1 (pl)
WO (1) WO2010136526A1 (pl)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8329869D0 (en) * 1983-11-09 1983-12-14 Janssen Pharmaceutica Nv Isolating levamisole from tetramisole
JO2654B1 (en) * 2000-09-04 2012-06-17 شركة جانسين فارماسوتيكا ان. في Multiple aryl caroxa amides are useful as lipid - lowering agents
JO2390B1 (en) 2001-04-06 2007-06-17 شركة جانسين فارماسوتيكا ان. في Diphenylcarboxamides act as lipid-lowering agents

Also Published As

Publication number Publication date
US20120071660A1 (en) 2012-03-22
EP2435406A1 (en) 2012-04-04
ES2412081T3 (es) 2013-07-10
JP2012528118A (ja) 2012-11-12
JP5596134B2 (ja) 2014-09-24
CN102448934B (zh) 2014-04-02
DK2435406T3 (da) 2013-05-13
SI2435406T1 (sl) 2013-06-28
EP2435406B1 (en) 2013-03-06
HRP20130393T1 (hr) 2013-05-31
CA2757702A1 (en) 2010-12-02
AU2010251910A1 (en) 2011-11-03
CY1114406T1 (el) 2016-08-31
PT2435406E (pt) 2013-05-08
AU2010251910B2 (en) 2014-07-10
KR20120016246A (ko) 2012-02-23
EA201171476A1 (ru) 2012-05-30
CA2757702C (en) 2016-10-11
US8461341B2 (en) 2013-06-11
CN102448934A (zh) 2012-05-09
KR101658880B1 (ko) 2016-09-30
WO2010136526A1 (en) 2010-12-02
EA018296B1 (ru) 2013-06-28

Similar Documents

Publication Publication Date Title
IL276157A (en) Pharmaceutical preparations and methods for transferring them related to them
IL206201A (en) Salts of 2– {4 - [(3s) - piperidine – 3 – ram] phenyl} –2 h– indazole-7-carboxamide-compatible pharmaceuticals and their uses
ZA201007522B (en) Methods and compositions for oral administration of proteins
IL221795A0 (en) Formulations for parenteral delivery of compounds and uses thereof
IL202680A0 (en) Formulations of nonopioid and confined opioid analgesics
IL206835A0 (en) Methods and compositions for oral administration of insulin
IL231463A0 (en) Carboxamide compounds and its use in the preparation of a medicine
IL209431A0 (en) Novel salts of (4-{[(5-{[(3-chlorophenyl)methyl]oxy}-2-methylphenyl)carbonyl]amino}-3-methylphenyl)acetic acid
IL208794A0 (en) Oral administration of peripherally-acting opioid antagonists
IL232457A0 (en) Quinolone compound and pharmaceutical preparation
SI2223684T1 (sl) Farmacevtski sestavek s podaljšanim sproščanjem oktreotidnega acetata
IL201894A (en) A quinolone compound and a @pharmaceutical containing @
EP2152232A4 (en) METHOD AND COMPOSITIONS FOR OXYBUTYNINE ADMINISTRATION
IL205309A (en) Induced compounds of indzole carbonyl amino amino methyl piperidine ethyl benzylic acid, their preparation and preparations containing them
PL2435406T3 (pl) Rozdzielanie (±)-fenylo[4-[4-[[[4'-(trifluorometylo)-2-bifenylilo]karbonylo]amino]fenylo]-1-piperydynylo] octanu metylu
IL245352A0 (en) Methods and preparations for administering proteins orally
IL208165A0 (en) Methods and compositions for oral administration of proteins
IL210842A0 (en) Methods and compositions for oral administration of proteins
IL198994A0 (en) Use of incensole and incensole acetate for the preparation of pharmaceutical compositions